CFTR and cystic fibrosis: In the first nonviral clinical trial by Caplen et al., a cationic lipid complexed with CFTR showed partial NPD correction of cAMP-mediated Cl− transport in the nasal epithelium of six people with CF, that approximated 20% of non-CF levels [106,107,108].